ProQR Therapeutics (PRQR)
Develops Axiomer RNA-editing medicines, led by AX-0810 for cholestatic diseases.
$2.30
Pre-market+0.14 (+6.73%)
At close$2.16(+1.65%)
Something off on this page? Send us feedback.
Next report
Nov 5, 2026
estimated · in 63 days
EPS estimate
−$0.11
Revenue estimate
$3.8M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.10−$0.11−$0.14−$0.12−$0.09−$0.15−$0.10Pending
Estimate−$0.10−$0.09−$0.08−$0.10−$0.08−$0.15−$0.13−$0.11
Surprise0.0%−22.2%−75.0%−20.0%−12.5%0.0%+23.2%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$4.5M$5.0M$4.5M$3.4M$5.5M$2.3M$10.0MPending
Estimate$5.4M$4.8M$5.5M$6.1M$6.6M$5.2M$4.6M$3.8M
Surprise−18.1%+3.1%−18.2%−44.2%−16.4%−54.7%+119.3%—
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.11 | — | — |
| Aug 2026 | −$0.13 | −$0.10 | +23.2% |
| May 2026 | −$0.15 | −$0.15 | 0.0% |
| Mar 2026 | −$0.08 | −$0.09 | −12.5% |
| Nov 2025 | −$0.10 | −$0.12 | −20.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 5, 2026 | −$0.11 | — | — | $3.8M | — | — | — |
| Aug 13, 2026 | −$0.13 | −$0.10 | +23.2% | $4.6M | $10.0M | +119.3% | −0.5% |
| May 12, 2026 | −$0.15 | −$0.15 | 0.0% | $5.2M | $2.3M | −54.7% | +6.3% |
| Mar 12, 2026 | −$0.08 | −$0.09 | −12.5% | $6.6M | $5.5M | −16.4% | +5.8% |
| Nov 6, 2025 | −$0.10 | −$0.12 | −20.0% | $6.1M | $3.4M | −44.2% | +0.5% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||||||
| Aug 7, 2025 | |||||||
| May 8, 2025 | |||||||
| Mar 13, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 9, 2024 | |||||||
| Mar 13, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 3, 2023 | |||||||
| May 16, 2023 | |||||||
| Mar 29, 2023 | |||||||
| Nov 9, 2022 | |||||||
| Aug 4, 2022 | |||||||
| May 5, 2022 | |||||||
| Feb 24, 2022 | |||||||
| Nov 4, 2021 | |||||||
| Aug 5, 2021 | |||||||
| May 6, 2021 | |||||||
| Feb 25, 2021 | |||||||
| Nov 16, 2020 | |||||||
| Aug 6, 2020 | |||||||
| May 7, 2020 | |||||||
| Feb 26, 2020 | |||||||
| Nov 6, 2019 | |||||||
| Aug 7, 2019 | |||||||
| May 8, 2019 | |||||||
| Feb 27, 2019 | |||||||
| Nov 7, 2018 | |||||||
| Aug 8, 2018 | |||||||
| May 9, 2018 | |||||||
| Feb 28, 2018 | |||||||
| Nov 20, 2017 | |||||||
| Aug 16, 2017 | |||||||
| May 17, 2017 | |||||||
| Feb 28, 2017 | |||||||
| Nov 14, 2016 | |||||||
| Aug 17, 2016 | |||||||
| May 18, 2016 | |||||||
| Feb 17, 2016 | |||||||
| Nov 23, 2015 | |||||||
| Aug 19, 2015 | |||||||